Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 01, 2023

SELL
$9.85 - $13.17 $98 - $131
-10 Reduced 0.08%
11,970 $154,000
Q1 2023

May 02, 2023

SELL
$9.44 - $11.88 $118,472 - $149,094
-12,550 Reduced 51.16%
11,980 $117,000
Q4 2022

Feb 07, 2023

SELL
$10.27 - $13.29 $232,574 - $300,965
-22,646 Reduced 48.0%
24,530 $260,000
Q3 2022

Oct 18, 2022

SELL
$9.93 - $17.44 $1,986 - $3,488
-200 Reduced 0.42%
47,176 $493,000
Q2 2022

Aug 03, 2022

BUY
$7.45 - $12.83 $789 - $1,359
106 Added 0.22%
47,376 $665,000
Q1 2022

May 03, 2022

BUY
$9.75 - $14.44 $105,202 - $155,807
10,790 Added 29.58%
47,270 $512,000
Q4 2021

Feb 08, 2022

BUY
$13.17 - $20.94 $227,577 - $361,843
17,280 Added 90.0%
36,480 $513,000
Q2 2021

Jul 20, 2021

BUY
$7.25 - $10.99 $47,850 - $72,534
6,600 Added 52.38%
19,200 $189,000
Q1 2021

May 18, 2021

BUY
$4.57 - $11.18 $57,582 - $140,868
12,600 New
12,600 $124,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.44B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Firethorn Wealth Partners, LLC Portfolio

Follow Firethorn Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Firethorn Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Firethorn Wealth Partners, LLC with notifications on news.